Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
175 hedge funds and large institutions have $1.43B invested in Exact Sciences in 2014 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 43 increasing their positions, 63 reducing their positions, and 21 closing their positions.
95% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 21
22% more call options, than puts
Call options by funds: $92.9M | Put options by funds: $75.9M
12% more funds holding
Funds holding: 156 → 175 (+19)
5% more capital invested
Capital invested by funds: $1.36B → $1.43B (+$72.3M)
32% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 63
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$26.6M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$23.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2M |
| 4 |
TI
Tyrian Investments
New York
|
+$11M |
| 5 |
O
OppenheimerFunds
New York
|
+$9.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tiger Global Management
New York
|
-$34.1M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$25.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$22M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$17M |
| 5 |
Goldman Sachs
New York
|
-$15.7M |
EXAS Hedge Fund Activity: Q3 2014 in Review
175 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2014, worth a combined $1.43B — up 5.3% from $1.36B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new EXAS positions and 21 closed out — a net gain of 20 holders — while 43 added to existing stakes and 63 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $26.6M. The largest seller was Tiger Global Management, exiting entirely with an estimated $34.1M sold.
- 175 institutional investors held Exact Sciences (EXAS) as of Q3 2014, up from 156 in Q2 2014.
- Funds reported $1.43B of Exact Sciences stock for Q3 2014, up 5.3% quarter-over-quarter.
- 41 funds opened new Exact Sciences positions in Q3 2014 and 21 closed out, a net change of +20 holders.
- The largest Exact Sciences buyer in Q3 2014 was Capital Research Global Investors, an estimated $26.6M added.
- The largest Exact Sciences seller in Q3 2014 was Tiger Global Management, an estimated $34.1M sold.
Based on aggregated 13F filings for Q3 2014.